Efficient Marek's disease virus (MDV) and herpesvirus of turkey infection of the QM7 cell line that does not contain latent MDV genome
- PMID: 25204414
- DOI: 10.1080/03079457.2014.956687
Efficient Marek's disease virus (MDV) and herpesvirus of turkey infection of the QM7 cell line that does not contain latent MDV genome
Abstract
Marek's disease virus (MDV; also known as Gallid herpesvirus 2, MDV-1) causes oncogenic disease in chickens producing clinical signs that include lymphomas, visceral tumours, nerve lesions, and immunosuppression. MDV vaccines are widely used and mostly produced using primary cells: chicken embryo fibroblast cells, duck embryo fibroblast cells, chicken embryo kidney cells or chicken kidney cells. An immortalized cell line that can be used to manufacture the virus has long been desired. In this report, we demonstrate that QM7 cells were susceptible to infection with either MDV or herpesvirus of turkey (HVT; also known as Meleagrid herpesvirus 1, MDV-3). Polymerase chain reaction analysis with primers amplifying selected MDV genes revealed that QM7 cells did not contain these sequences. However, MDV genes were detected in QT35 cells, which have been reported to harbour latent MDV virus. Transfection of naked MDV DNA initiated efficient infection of QM7 cells. In addition, QM7 cell lysate, clarified supernatant, and QM7 cell pellet infected with MDV were negative for reverse transcriptase activity, indicating absence of endogenous retrovirus. QM7 cells were also found to be free of other avian pathogens in a chick embryo inoculation test. In vivo studies of MDV growing in QM7 cells showed the virus retained its pathogenicity and virulence. In ovo experiments demonstrated that both HVT and MDV propagated in QM7 cells did not interfere with hatchability of injected eggs, and viruses could be re-isolated from hatched chicks. The results suggest that QM7 could be a good host cell line for growing both MDV and HVT.
Similar articles
-
The Influence of Major Histocompatibility Complex and Vaccination with Turkey Herpesvirus on Marek's Disease Virus Evolution.Avian Dis. 2015 Mar;59(1):122-9. doi: 10.1637/10677-092413-reg. Avian Dis. 2015. PMID: 26292545
-
Targeted Deletion of Glycoprotein B Gene by CRISPR/Cas9 Nuclease Inhibits Gallid herpesvirus Type 3 in Dually Infected Marek's Disease Virus-Transformed Lymphoblastoid Cell Line MSB-1.J Virol. 2022 Mar 23;96(6):e0202721. doi: 10.1128/jvi.02027-21. Epub 2022 Feb 2. J Virol. 2022. PMID: 35107377 Free PMC article.
-
Kinetics of Marek's disease virus (MDV) infection in broiler chickens 1: effect of varying vaccination to challenge interval on vaccinal protection and load of MDV and herpesvirus of turkey in the spleen and feather dander over time.Avian Pathol. 2008 Jun;37(3):225-35. doi: 10.1080/03079450701802230. Avian Pathol. 2008. PMID: 18568648 Clinical Trial.
-
Use of Marek's disease vaccines: could they be driving the virus to increasing virulence?Expert Rev Vaccines. 2005 Feb;4(1):77-88. doi: 10.1586/14760584.4.1.77. Expert Rev Vaccines. 2005. PMID: 15757475 Review.
-
Marek's disease virus morphogenesis.Avian Dis. 2013 Jun;57(2 Suppl):340-50. doi: 10.1637/10375-091612-Review.1. Avian Dis. 2013. PMID: 23901745 Review.
Cited by
-
Marek's disease virus in vaccinated poultry flocks in Turkey: its first isolation with molecular characterization.Arch Virol. 2021 Feb;166(2):559-569. doi: 10.1007/s00705-020-04943-6. Epub 2021 Jan 6. Arch Virol. 2021. PMID: 33409548
-
Replication of Vectored Herpesvirus of Turkey (HVT) in a Continuous, Microcarrier-Independent Suspension Cell Line from Muscovy Duck.Vaccines (Basel). 2025 Jun 30;13(7):714. doi: 10.3390/vaccines13070714. Vaccines (Basel). 2025. PMID: 40733691 Free PMC article.
-
The Modulation of Apoptotic Pathways by Gammaherpesviruses.Front Microbiol. 2016 Apr 27;7:585. doi: 10.3389/fmicb.2016.00585. eCollection 2016. Front Microbiol. 2016. PMID: 27199919 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources